Treating solid tumors with an antibody to hepatocyte growth factor
US7687063B2 · kind B2 · utility
10Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2007 |
| Grant date | Mar 30, 2010 |
| Priority date | — |
| Expiry date | Jun 13, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4753
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.